PHOENIX, Ariz. (February 17, 2020) — The Board of Directors at Vālenz™ has appointed Amy Gasbarro as Chief Operating Officer. Since 2018, Gasbarro has served as President of Vālenz Care, the firm’s care management solution.

“I commend the Board for their decision to appoint Amy to this role,” said Rob Gelb, the firm’s new Chief Executive Officer, adding that Gasbarro’s leadership background spans two decades at companies focused on population health and cost management solutions for self-funded employers. “Her expertise, combined with her shared vision for the future of Valenz, make her an excellent choice to oversee operations for the next high-growth phase of our company.”

In addition to her leadership role at Valenz, Gasbarro is actively involved in committees that advocate for self-insured employers, including the Government Relations Committee for the Self-Insurance Institute of America (SIIA) and the SIIA Political Action Committee. Such involvement ensures she has a seat at the table as a voice for self-funded groups, helping to steer public policy in support of favorable outcomes – namely, lower-cost, higher-quality healthcare.

Those outcomes are at the heart of everything they do at Valenz, says Gasbarro, where delivering on the company’s promise involves taking every opportunity to engage early and often for smarter, better, faster healthcare. As COO, Gasbarro is committed to supporting the Valenz team as the enterprise grows, and as its flagship platform – the industry’s first complete, end-to-end health administrative ecosystem – expands.

“Through the analytic and predictive power of the Valenz ecosystem, we are continuously broadening our ability to influence better health outcomes and reduce total cost of care,” said Gasbarro. “This is a very exciting time for Valenz, and I look forward to my new role in shaping a more prosperous future for our company, and more importantly, for our clients.”

About Valenz
Through a complete health administrative ecosystem, Valenz connects cost and quality data on a single-source, end-to-end analytics platform for smarter, better, faster healthcare. Valenz solutions integrate data from comprehensive care management services (Valenz Care), high-value provider networks (Valenz Access), claim flow management (Valenz Claim), and solutions for payment integrity, revenue cycle management and eligibility compliance (Valenz Assurance) into the ecosystem. For more information, visit www.valenzhealth.com. Valenz is backed by Great Point Partners.

About Great Point Partners
Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading healthcare investment firm, currently with approximately $1.8 billion of equity capital under management and 28 professionals, investing in the United States, Canada and Western Europe. Learn more at www.gppfunds.com.

PHOENIX, Ariz. (January 9, 2020) – Vālenz™ is pleased to announce that it has become a Diamond member company of the Self-Insurance Institute of America, Inc. (SIIA). Diamond membership signifies the highest level of support for SIIA and demonstrates a company’s leadership position within the self-insurance/captive insurance marketplace.

“We are proud and honored to support SIIA in its mission, and our recent decision to become a Diamond member reflects the strength of our commitment – and theirs – to serving the needs of the self-insured community,” said Valenz Chief Revenue Officer Rob Gelb. “Our involvement with SIIA over the years has been integral to our ability to develop innovative solutions that reduce medical claim costs and promote quality healthcare. Diamond member status is one of many ways we are giving back to an organization that has given so much to us, and to the self-insured community we serve daily.”

Through a complete health administrative ecosystem that connects cost and quality data on a single-source, end-to-end analytics platform, Valenz helps self-insured employers achieve smarter, better, faster healthcare at significant cost savings. By integrating data from its core services – which comprise care management, high-value provider networks, claim workflow management, payment integrity, revenue cycle management and eligibility compliance – Valenz delivers solutions that reduce total cost of care while improving health outcomes for America’s workforce.

The continued growth in the number of SIIA Diamond members reflects recognition by leading-industry companies of the importance to provide robust support to the trade association that is best positioned to protect and promote their business interests. This support has enabled SIIA to further improve and expand its membership service capabilities. Learn more at siia.org.

About Valenz

Through a complete health administrative ecosystem, Valenz connects cost and quality data on a single-source, end-to-end analytics platform for smarter, better, faster healthcare. Serving self-insured employers, third-party claim administrators, brokers and benefit consultants, trust and labor organizations, stop-loss carriers, integrated healthcare delivery networks, and health/dental plan payers, Valenz solutions integrate data from comprehensive care management services (Valenz Care), high-value provider networks (Valenz Access), claim flow management (Valenz Claim) and solutions for payment integrity, revenue cycle management and eligibility compliance (Valenz Assurance) into the ecosystem. Valenz is backed by Great Point Partners. To learn more about Valenz, visit www.valenzhealth.com

About Great Point Partners

Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading healthcare investment firm, currently with approximately $1.8 billion of equity capital under management and 28 professionals, investing in the United States, Canada and Western Europe. GPP is currently making new private equity investments from GPP III. Great Point manages capital in private (GPP I, $156 million and GPP II, $215 million of committed capital, and GPP III which has $306 million in committed capital) and public (BioMedical Value Fund family, approximately $1.1 billion) equity funds. Great Point Partners has provided growth equity, growth recapitalization, and management buyout financing to more than 100 growing healthcare companies. The private equity funds invest across all sectors of the healthcare industry, with particular emphasis on biopharmaceutical services and supplies, outsourcing and alternate site care, pharmaceutical infrastructure and information technology-enabled businesses. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies. Learn more at www.gppfunds.com.

PHOENIX, Ariz. (January 8, 2020) — To support continuous expansion of the Vālenz™ ecosystem and deliver solutions that meet the ever-evolving needs of their clients and partners, Valenz officials today announced the appointment of Tom Cox, MBA, as Vice President of Client Services. Cox joins the team in mid-January to lead the client services and business development support teams.

“Tom has a deep conviction for delivering service excellence and creating value for clients, partners and shareholders,” said Rob Gelb, Chief Revenue Officer. “His leadership experience and ability to leverage data for client solutions have positioned him well to head up our client services team.”

Cox says he has always been passionate about delivering service excellence because he believes great service is the key to strong, long-lasting relationships. In addition to overseeing client services – the first point of contact for the firm’s large and growing client base – Cox plays a key role in data-driven growth and development of existing business.

“With healthcare as complex as it is, I am really excited about the depth of Valenz analytics,” said Cox. “We have a great line of sight into client trends and needs, allowing us to pinpoint opportunities to truly bend the cost curve in healthcare.”

Having held a number of leadership positions in customer service, most recently at Philadelphia Insurance Companies and Aqua America, Cox brings extensive experience to his new role. He earned his master’s degree from Arcadia University in Pennsylvania after completing his bachelor’s degree in psychology from the State University of New York at Albany. He is also nationally certified in coaching, training and facilitation. His education, combined with more than a decade of versatile business experience, has inspired Cox to deliver creative approaches, fresh thinking and data-driven insights to service delivery.

About Valenz

Through a complete health administrative ecosystem, Valenz connects cost and quality data on a single-source, end-to-end analytics platform for smarter, better, faster healthcare. Serving self-insured employers, third-party claim administrators, brokers and benefit consultants, trust and labor organizations, stop-loss carriers, integrated healthcare delivery networks, and health/dental plan payers, Valenz solutions integrate data from comprehensive care management services (Valenz Care), high-value provider networks (Valenz Access), claim flow management (Valenz Claim) and solutions for payment integrity, revenue cycle management and eligibility compliance (Valenz Assurance) into the ecosystem. Valenz is backed by Great Point Partners.

About Great Point Partners

Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading healthcare investment firm, currently with approximately $1.8 billion of equity capital under management and 28 professionals, investing in the United States, Canada and Western Europe. GPP is currently making new private equity investments from GPP III. Great Point manages capital in private (GPP I, $156 million and GPP II, $215 million of committed capital, and GPP III which has $306 million in committed capital) and public (BioMedical Value Fund family, approximately $1.1 billion) equity funds. Great Point Partners has provided growth equity, growth recapitalization, and management buyout financing to more than 100 growing healthcare companies. The private equity funds invest across all sectors of the healthcare industry, with particular emphasis on biopharmaceutical services and supplies, outsourcing and alternate site care, pharmaceutical infrastructure and information technology-enabled businesses. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies. For more information, visit www.gppfunds.com.

PHOENIX, Ariz. (December 19, 2019) — With a laser focus on changing the trajectory of total healthcare spending, which surpassed $3.6 trillion in 2018 and is expected to rise 5.5% to exceed $3.8 trillion in 2019, Vālenz™ announced the integration of Spiro into its health administrative ecosystem. As a proactive relationship management solution typically used to boost efficiency and effectiveness, Spiro provides Valenz teams with a transparent lens into new and existing client activity. The resulting insights quickly illuminate new ways to disrupt the cost curve for Valenz clients, which include self-insured employers, third-party claim administrators, brokers and benefit consultants, trust and labor organizations, stop-loss carriers, integrated healthcare delivery networks, and health/dental plan payers.

“By embedding Spiro into our business processes, we can extract meaningful data from client interactions, giving everyone across our enterprise actionable business intelligence to help our clients reduce their total cost of care,” said Rob Gelb, Chief Revenue Officer at Valenz. Spiro’s AI platform offers tremendous efficiencies for the Valenz team and, as Gelb explains, “It’s a game-changer for our clients because now we can consolidate their information across text messages, calls and documents to rapidly deploy new solutions for our clients.”

According to Adam Honig, CEO and co-founder of Spiro, companies that use Spiro’s AI-driven, proactive relationship management platform can expect to work smarter and close faster – and for innovative firms like Valenz, there are opportunities to take things to the next level. “I’m impressed at how Valenz is integrating our platform into its ecosystem to generate value well beyond their own benefit,” Honig said. “They are clearly a forward-thinking firm, using our platform to engage early and often to reduce the cost of healthcare for their clients.”

About Valenz

Through a complete health administrative ecosystem, Valenz connects cost and quality data on a single-source, end-to-end analytics platform for smarter, better, faster healthcare. Serving self-insured employers, third-party claim administrators, brokers and benefit consultants, trust and labor organizations, stop-loss carriers, integrated healthcare delivery networks, and health/dental plan payers, Valenz solutions integrate data from comprehensive care management services (Valenz Care), high-value provider networks (Valenz Access), claim flow management (Valenz Claim) and solutions for payment integrity, revenue cycle management and eligibility compliance (Valenz Assurance) into the ecosystem. Valenz is backed by Great Point Partners.

About Spiro.AI

Spiro is the first proactive relationship management platform. Natively built on artificial intelligence, Spiro provides a single solution encompassing traditional CRM, sales enablement and telephony. Spiro’s AI engine eliminates the need for data entry and proactively guides salespeople to the right actions at the right time. Customers report collecting 8 times more data, reaching 47% more prospects and closing 20% more deals after using Spiro. For more information, visit www.spiro.ai.

About Great Point Partners

Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading healthcare investment firm, currently with approximately $1.8 billion of equity capital under management and 28 professionals, investing in the United States, Canada and Western Europe. GPP is currently making new private equity investments from GPP III. Great Point manages capital in private (GPP I, $156 million and GPP II, $215 million of committed capital, and GPP III which has $306 million in committed capital) and public (BioMedical Value Fund family, approximately $1.1 billion) equity funds. Great Point Partners has provided growth equity, growth recapitalization and management buyout financing to more than 100 growing healthcare companies. The private equity funds invest across all sectors of the healthcare industry, with particular emphasis on biopharmaceutical services and supplies, outsourcing and alternate site care, pharmaceutical infrastructure and information technology-enabled businesses. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies. Visit Great Point at www.gppfunds.com.

Vālenz™, a leading innovator for solutions that reduce medical claim costs and promote quality healthcare, recently welcomed Ben Inabinet to the team as Senior Sales Executive. As an experienced sales professional and account executive, Inabinet has a proven track record of delivering efficiency and cost savings through IT solutions for third-party administrators, insurance carriers, self-insured employers and other clients.

Prior to joining Valenz, Inabinet worked as a Channel Manager for NetClaim. His work experience also includes sales and account positions at such firms as Team IA and ScanSource. Today, he says he is thrilled to bring his career to the next level through Valenz and the industry’s first complete health administrative ecosystem.

“As healthcare spending continues to rise, today’s health administrators need new approaches that drive lower costs and better outcomes,” Inabinet said. “Valenz helps clients achieve smarter, better, faster healthcare through highly integrated, data-driven solutions, so I am truly honored to join such a client-centric and future-focused team.”

Rob Gelb, Chief Revenue Officer, says Inabinet brings the right mix of industry knowledge, problem-solving skills and innovative spirit to the Valenz sales team, which is integral to serving the needs of Valenz’s customer base. “The more we grow, the more robust our analytic and predictive capabilities become, making our ecosystem grow in value for our clients every day,” Gelb explained.

For more information, call 866-762-4455.

About Valenz

Through a complete health administrative ecosystem, Valenz connects cost and quality data on a single-source, end-to-end analytics platform for smarter, better, faster healthcare. Serving self-insured employers, third-party claim administrators, brokers and benefit consultants, trust and labor organizations, stop-loss carriers, integrated healthcare delivery networks, and health/dental plan payers, Valenz solutions integrate data from comprehensive care management services (Valenz Care), high-value provider networks (Valenz Access), claim flow management (Valenz Claim) and solutions for payment integrity, revenue cycle management and eligibility compliance (Valenz Assurance) into the ecosystem. More information is available online at valenzhealth.com. Valenz is backed by Great Point Partners. For more information about Valenz, visit www.valenzhealth.com or call (866) 762-4455.

About Great Point Partners

Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading health care investment firm, currently with approximately $1.8 billion of equity capital currently under management and 28 professionals, investing in the United States, Canada, and Western Europe. GPP is currently making new private equity investments from GPP III. Great Point manages capital in private (GPP I, $156 million and GPP II, $215 million of committed capital, and GPP III which has $306 million in committed capital) and public (BioMedical Value Fund family, approximately $1.1 billion) equity funds. Great Point Partners has provided growth equity, growth recapitalization, and management buyout financing to more than 100 growing health care companies. The private equity funds invest across all sectors of the health care industry with particular emphasis on biopharmaceutical services and supplies, outsourcing and alternate site care, pharmaceutical infrastructure and information technology enabled businesses. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies. Reach Great Point at (203) 971-3300 or www.gppfunds.com.